Patients come in all sizes and shapes, and with varying tolerance for complications and risk. Is it plausible that a single dosing regimen can optimize treatment for everybody?
We revisit the question of brain death, this time with a more practical focus. What should doctors tell families of patients who fulfill neurological criteria for brain death?
Economic knowledge should not be the sole province of technical experts, but it is. The price we pay for this ignorance is that most people can easily fall prey to the political class and to the technocrats whose economic theory is generally far from sound.
Bureaucratic appeal to measurement as a check on personal judgment rules the medical field but also permeates our entire culture. Guest Jerry Z. Muller brings a valuable historical perspective to the subject.
